首页> 外文期刊>International journal of immunopathology and pharmacology. >Validation of a Diagnostic Score for the Diagnosis of Autoinflammatory Diseases in Adults
【24h】

Validation of a Diagnostic Score for the Diagnosis of Autoinflammatory Diseases in Adults

机译:成人自发性疾病诊断诊断评分的验证

获取原文

摘要

Most autoinflammatory disorders typically come out in the pediatric population, although a limited number of patients may experience disease onset during adulthood. To date, a late disease onset has been described only in familial Mediterranean fever, caused by mutations in the MEFV gene, and in tumor necrosis factor receptor-associated periodic syndrome, caused by mutations in the TNFRSF1A gene. The relative rarity and lack of information on adult-onset autoinflammatory diseases make it likely that mutations will be found in an even smaller percentage of cases. With the aim of improving the genetic diagnosis in adults with suspected autoinflammatory disorders, we recently identified a set of variables related to the probability of detecting gene mutations in MEFV and TNFRSF1A and, in addition, we have also proposed a diagnostic score for identifying those patients at high risk of carrying mutations in these genes. In the present study we evaluated the preliminary score sensitivity and specificity on a wider number of patients in order to validate the goodness of fit of the model. Two hundred and nineteen consecutive patients with a clinical history of periodic fever attacks were screened for mutations in MEFV and TNFRSF1A genes; detailed information about family/personal history and clinical manifestations were also collected. For the validation of the score we considered data both from the 110 patients used to build the preliminary diagnostic score and from the additional 219 patients enrolled in the present study, for a total number of 329 patients. Early age at disease onset, positive family history for recurrent fever episodes, thoracic pain, abdominal pain and skin rash, which are the variables that had previously been shown to be significantly associated with a positive genetic test result (12), were used for validation. On univariate analysis the associations with a positive genetic test were: age at onset (odds ratio [OR] 0.43, p=0.003), positive family history for recurrent fever episodes (OR 5.81, p<0.001), thoracic pain (OR 3.17, p<0.001), abdominal pain (OR 3.80, p<0.001) and skin rash (OR 1.58, p=0.103). The diagnostic score was calculated using the linear combination of the estimated coefficients of the logistic multivariate model (cut-off equals to 0.24) revealing good sensitivity (0.778) and good specificity (0.718). In conclusion, our score may serve in the diagnostic evaluation of adult patients presenting with recurrent fever episodes suspected of having an autoinflammatory disorder, helping identify the few subjects among them who may be carriers of mutations in MEFV and TNFRSF1A genes.
机译:大多数自发炎性疾病通常发生在儿科人群中,尽管少数患者可能会在成年期经历疾病发作。迄今为止,仅在由MEFV基因突变引起的家族性地中海热和由TNFRSF1A基因突变引起的肿瘤坏死因子受体相关的周期性综合征中描述了晚期疾病发作。由于成人罕见的自发性炎性疾病相对稀少且缺乏信息,因此有可能在更小比例的病例中发现突变。为了改善可疑自体炎症性疾病成年人的遗传诊断,我们最近鉴定了一组与检测MEFV和TNFRSF1A基因突变的可能性有关的变量,此外,我们还提出了一个诊断分数来识别那些患者这些基因中携带突变的风险很高。在本研究中,我们评估了更多患者的初步评分敏感性和特异性,以验证模型拟合的良好性。筛选了119例具有周期性发烧发作临床病史的患者,以寻找MEFV和TNFRSF1A基因的突变;还收集了有关家庭/个人病史和临床表现的详细信息。为了验证评分,我们考虑了来自用于建立初步诊断评分的110位患者以及本研究中招募的219位患者的数据。疾病发作时的早年,反复发烧发作的家族史,胸痛,腹痛和皮疹为阳性,这些变量先前已被证明与阳性基因检测结果显着相关(12),用于验证。在单因素分析中,与阳性基因测试相关的因素包括:发病年龄(几率[OR] 0.43,p = 0.003),复发性发烧家族史阳性(OR 5.81,p <0.001),胸痛(OR 3.17, p <0.001),腹痛(OR 3.80,p <0.001)和皮疹(OR 1.58,p = 0.103)。使用逻辑多变量模型的估计系数的线性组合(截断值等于0.24)来计算诊断评分,从而显示出良好的敏感性(0.778)和良好的特异性(0.718)。总之,我们的评分可能有助于诊断患有自发性疾病的反复发作的成年患者,从而帮助他们确定少数可能携带MEFV和TNFRSF1A基因突变的受试者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号